These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 36581615)

  • 1. Metabolic contributions to neuronal deficits caused by genomic disruption of schizophrenia risk gene SETD1A.
    Chong ZS; Khong ZJ; Tay SH; Ng SY
    Schizophrenia (Heidelb); 2022 Dec; 8(1):115. PubMed ID: 36581615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss-of-function variants in the schizophrenia risk gene SETD1A alter neuronal network activity in human neurons through the cAMP/PKA pathway.
    Wang S; Rhijn JV; Akkouh I; Kogo N; Maas N; Bleeck A; Ortiz IS; Lewerissa E; Wu KM; Schoenmaker C; Djurovic S; van Bokhoven H; Kleefstra T; Nadif Kasri N; Schubert D
    Cell Rep; 2022 May; 39(5):110790. PubMed ID: 35508131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recapitulation and Reversal of Schizophrenia-Related Phenotypes in Setd1a-Deficient Mice.
    Mukai J; Cannavò E; Crabtree GW; Sun Z; Diamantopoulou A; Thakur P; Chang CY; Cai Y; Lomvardas S; Takata A; Xu B; Gogos JA
    Neuron; 2019 Nov; 104(3):471-487.e12. PubMed ID: 31606247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of SETD1A haploinsufficiency in humans and Drosophila defines a novel neurodevelopmental syndrome.
    Kummeling J; Stremmelaar DE; Raun N; Reijnders MRF; Willemsen MH; Ruiterkamp-Versteeg M; Schepens M; Man CCO; Gilissen C; Cho MT; McWalter K; Sinnema M; Wheless JW; Simon MEH; Genetti CA; Casey AM; Terhal PA; van der Smagt JJ; van Gassen KLI; Joset P; Bahr A; Steindl K; Rauch A; Keller E; Raas-Rothschild A; Koolen DA; Agrawal PB; Hoffman TL; Powell-Hamilton NN; Thiffault I; Engleman K; Zhou D; Bodamer O; Hoefele J; Riedhammer KM; Schwaibold EMC; Tasic V; Schubert D; Top D; Pfundt R; Higgs MR; Kramer JM; Kleefstra T
    Mol Psychiatry; 2021 Jun; 26(6):2013-2024. PubMed ID: 32346159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developmental disruption to the cortical transcriptome and synaptosome in a model of SETD1A loss-of-function.
    Clifton NE; Bosworth ML; Haan N; Rees E; Holmans PA; Wilkinson LS; Isles AR; Collins MO; Hall J
    Hum Mol Genet; 2022 Sep; 31(18):3095-3106. PubMed ID: 35531971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex-dependent effects of Setd1a haploinsufficiency on development and adult behaviour.
    Bosworth ML; Isles AR; Wilkinson LS; Humby T
    PLoS One; 2024; 19(8):e0298717. PubMed ID: 39141687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SETD1A Mediated H3K4 Methylation and Its Role in Neurodevelopmental and Neuropsychiatric Disorders.
    Wang S; Bleeck A; Nadif Kasri N; Kleefstra T; van Rhijn JR; Schubert D
    Front Mol Neurosci; 2021; 14():772000. PubMed ID: 34803610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional Changes following Cellular Knockdown of the Schizophrenia Risk Gene
    Cameron D; Blake DJ; Bray NJ; Hill MJ
    Mol Neuropsychiatry; 2019 Apr; 5(2):109-114. PubMed ID: 31192223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Setd1a Insufficiency in Mice Attenuates Excitatory Synaptic Function and Recapitulates Schizophrenia-Related Behavioral Abnormalities.
    Nagahama K; Sakoori K; Watanabe T; Kishi Y; Kawaji K; Koebis M; Nakao K; Gotoh Y; Aiba A; Uesaka N; Kano M
    Cell Rep; 2020 Sep; 32(11):108126. PubMed ID: 32937141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant Cortical Ensembles and Schizophrenia-like Sensory Phenotypes in Setd1a
    Hamm JP; Shymkiv Y; Mukai J; Gogos JA; Yuste R
    Biol Psychiatry; 2020 Aug; 88(3):215-223. PubMed ID: 32143831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rare loss-of-function variants in SETD1A are associated with schizophrenia and developmental disorders.
    Singh T; Kurki MI; Curtis D; Purcell SM; Crooks L; McRae J; Suvisaari J; Chheda H; Blackwood D; Breen G; Pietiläinen O; Gerety SS; Ayub M; Blyth M; Cole T; Collier D; Coomber EL; Craddock N; Daly MJ; Danesh J; DiForti M; Foster A; Freimer NB; Geschwind D; Johnstone M; Joss S; Kirov G; Körkkö J; Kuismin O; Holmans P; Hultman CM; Iyegbe C; Lönnqvist J; Männikkö M; McCarroll SA; McGuffin P; McIntosh AM; McQuillin A; Moilanen JS; Moore C; Murray RM; Newbury-Ecob R; Ouwehand W; Paunio T; Prigmore E; Rees E; Roberts D; Sambrook J; Sklar P; St Clair D; Veijola J; Walters JT; Williams H; ; ; ; ; Sullivan PF; Hurles ME; O'Donovan MC; Palotie A; Owen MJ; Barrett JC
    Nat Neurosci; 2016 Apr; 19(4):571-7. PubMed ID: 26974950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell type-specific mechanism of Setd1a heterozygosity in schizophrenia pathogenesis.
    Chen R; Liu Y; Djekidel MN; Chen W; Bhattacherjee A; Chen Z; Scolnick E; Zhang Y
    Sci Adv; 2022 Mar; 8(9):eabm1077. PubMed ID: 35245111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histone methyltransferase SETD1A interacts with HIF1α to enhance glycolysis and promote cancer progression in gastric cancer.
    Wu J; Chai H; Xu X; Yu J; Gu Y
    Mol Oncol; 2020 Jun; 14(6):1397-1409. PubMed ID: 32291851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SETD1A variant-associated psychosis: A systematic review of the clinical literature and description of two new cases.
    Colijn MA; Carrion P; Poirier-Morency G; Rogic S; Torres I; Menon M; Lisonek M; Cook C; DeGraaf A; Thammaiah SP; Neelakant H; Willaeys V; Leonova O; White RF; Yip S; Mungall AJ; MacLeod PM; Gibson WT; Sullivan PF; Honer WG; Pavlidis P; Stowe RM
    Prog Neuropsychopharmacol Biol Psychiatry; 2024 Feb; 129():110888. PubMed ID: 37918557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysregulation of Neurite Outgrowth and Cell Migration in Autism and Other Neurodevelopmental Disorders.
    Prem S; Millonig JH; DiCicco-Bloom E
    Adv Neurobiol; 2020; 25():109-153. PubMed ID: 32578146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. De Novo and Inherited SETD1A Variants in Early-onset Epilepsy.
    Yu X; Yang L; Li J; Li W; Li D; Wang R; Wu K; Chen W; Zhang Y; Qiu Z; Zhou W
    Neurosci Bull; 2019 Dec; 35(6):1045-1057. PubMed ID: 31197650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CXXC finger protein 1 restricts the Setd1A histone H3K4 methyltransferase complex to euchromatin.
    Tate CM; Lee JH; Skalnik DG
    FEBS J; 2010 Jan; 277(1):210-23. PubMed ID: 19951360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel missense SETD1A variants in Japanese patients with schizophrenia: Resequencing and association analysis.
    Morikawa R; Watanabe Y; Igeta H; Arta RK; Ikeda M; Okazaki S; Hoya S; Saito T; Otsuka I; Egawa J; Tanifuji T; Iwata N; Someya T
    Psychiatry Res; 2022 Apr; 310():114481. PubMed ID: 35235885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The H3K4 methyltransferase Setd1a is first required at the epiblast stage, whereas Setd1b becomes essential after gastrulation.
    Bledau AS; Schmidt K; Neumann K; Hill U; Ciotta G; Gupta A; Torres DC; Fu J; Kranz A; Stewart AF; Anastassiadis K
    Development; 2014 Mar; 141(5):1022-35. PubMed ID: 24550110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An in vitro model of neuronal ensembles.
    Rabadan MA; De La Cruz ED; Rao SB; Chen Y; Gong C; Crabtree G; Xu B; Markx S; Gogos JA; Yuste R; Tomer R
    Nat Commun; 2022 Jun; 13(1):3340. PubMed ID: 35680927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.